Advertisement

Atrium Therapeutics, Inc. RNA

Set alert

Price alert · RNA

All alert types
8.27 USD +0.01 +0.12%

At close · Oct 30

8.27 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
8.27 × 2
Ask
8.31 × 2
7.88 Day range 8.31
7.61 52-week range 16.54
YTD
-43.93%
1 year
-43.93%
Open
8.19
Prev close
8.26
Mkt cap
141.46M
Vol
566.64K
Avg vol
272.10K
EPS
-5.44
P/E
0.00
Div yield
0.00%
More statistics
Low
7.88
High
8.31
Forward P/E
-3.67
Beta
0.00
Short ratio
0.00
Inst. own
0.25%
Dividend
0.00
Ex-div date
50-d avg
15.47
200-d avg
15.47
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for RNA has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $2.43MExpenses → Selling, General & Admin: $9.94MExpenses → Research & Development: $15.34MGross Profit → Expenses: $2.66MRevenue → Gross Profit: $2.66MRevenue → Cost of Revenue: $343.00KNet Loss → Expenses: $20.19MOther Income$2.43MGross Profit$2.66MNet Loss$20.19MCost of Revenue$343.00KExpenses$25.28MSelling, General & Admin$9.94MResearch & Development$15.34MRevenue$3.00M

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

RNA quarterly income statement
3.00M
3.00M
3.00M
25.62M
15.34M
10.28M
-22.62M
-20.19M
-20.19M
-20.19M
-20.19M
-1.18
-1.18
-1.18
-20.19M
-20.19M
17.11M
17.11M

Balance sheet

RNA quarterly balance sheet
72.64M
72.64M
191.67M
191.57M
106.00K
275.05M
5.36M
280.51M
1.68M
1.68M
31.51M
65.94M
-8.06M
-235.00K
214.58M
214.58M
5.46M
1.68M
42.69M
34.43M
3.51M

Cash flow

RNA quarterly cash flow
1.10M
-195.51M
-36.00K
-191.59M
-191.55M
-3.93M
893.00K
Advertisement